Introduction
Two important articles on aggregate mortality trends were published in the spring of 2002, with important implications for our perspective on modeling, forecasting, and interpreting mortality trends. One such article was Oeppen and Vaupel (2002, henceforth OV) , which shows a remarkable linear trend in the female life expectancy (at birth, period basis) of the national population with the highest value for this variable from 1840 to 2000. Of course the set of nations reporting credible life expectancy values has greatly expanded over this period, but that is unlikely to have mattered much for the results. Over this entire 160-year period, the record life expectancy consistently increased by .24 years of life per calendar year of time, or at the rate of 24 years per century. Extrapolation would lead us to expect a female life expectancy of around 108 years at the end of the 21 st century.
A closely related article by White (2002) finds a linear trend in sexes-combined life expectancy for 21 industrial nations from 1955 to 1995, with an increase of .21 years of life per calendar year. White also finds that a linear trend in life expectancy gives a better fit to the experience of almost all the individual countries than does a linear trend in the age-standardized death rate, or the log of the age standardized death rate. He also found that when a quadratic time trend was fitted to the standardized rates, the coefficient on the squared term was significantly positive, indicating that the rate of improvement has been accelerating.
Both OV and White discuss the processes of catch-up and convergence. OV notes that some countries converge toward the leader (e.g. Japan), some have moved away from it (e.g. the US in recent decades), and some move more or less parallel to it. White finds that nations experience more rapid e0 gains when they are farther below the international average, and conversely, and therefore tend to converge toward the average. The variance across countries has diminished markedly over the forty years. However, there has been no tendency for the rate of increase of average e0 to slow down. Based on the current position of the US, which is somewhat below the average (just as OV shows that the US is below the record line), White predicts that e0 will grow a bit more rapidly than the average rate of .21 years per year, perhaps at .22 years per year. At this rate, the US would reach e0=83.3 in 2030-about 1.5 years above the Lee-Carter (1992) forecast, and about 3.8 years above the Social Security Administration (2002) projection for that year.
Extrapolation of the linear trend in either OV or White generates more rapid gains in future longevity than are foreseen by Lee-Carter (1992, henceforth LC) , which projects increases of .144 years per year between now and 2030. This is only two-thirds as fast as .22 years per year in White, and .23 years per year in OV (averaging the female and male rates for OV).
Two major points are made in both articles. First, life expectancy (record or average) appears to have changed linearly over long periods of time. Second, national mortality trends should be viewed in a larger international context rather than being analyzed and projected individually. In this paper I will discuss both these points, and conclude with 2 suggestions for incorporating them in forecasting methods. I will draw on the Human Mortality Database, or HMD at http://www.mortality.org/, to fit various models. Figure 1 plots the OV maximum life expectancy together with that of the HMD and we see that they sometimes coincide, and sometimes the OV record exceeds the HMD, which includes fewer countries.
Linear Change in Life Expectancy Over Long Historical Periods
Before reading the OV article, I had expected that the trajectory of record life expectancy over the past two centuries would have a tilted S shape, in which life expectancy began at first to increase slowly, then accelerated, and then decelerated in the second half of the 20 th century. If we go back far enough in time, we know that life expectancy had no systematic trend at all, although there might have been long fluctuations. We also can be pretty sure that initial gains in life expectancy, once the trend began, were slow. Based on the OV results, it appears that these portions of the history occurred out of our sight, before the start date of 1840. Indeed, Figure 5 in the OV Supplementary Materials on the Science Web site, plots English life expectancy over a longer period, and its trajectory conforms to this description.
OV do not actually test or explore the constancy of the slope for record life expectancy, so it is worth examining this point more carefully here. As a start, we can compute the average rates of life expectancy increase for the OV data by sex and sub-period, as follows: From this we see that the regularity of the linear decline is not quite as strong as it appears from the striking figure in OV. For males in particular, there has been a noticeable deceleration over the past 50 years. For both sexes, there is a hint of the S shaped path that I had expected to see.
I have taken two more simple steps. First, I fitted a cubic polynomial to the data, and found that all three terms were significantly different than zero. The fitted curve, as shown in Figure 2 for females, does have a slight S-shape. To see more clearly the implied rate of change, I plot the first derivative of the polynomial for females in Figure  3 . This suggests that the rate of change in fact increased substantially, more than doubling from 1840 to 1925 or so, and then substantially declining again thereafter, challenging the linear interpretation of the OV plot. Second, I calculated a twenty-five-year moving average of the annual pace of increase for females, and this also is plotted in Figure 2 . This less severe smoothing of the rate of change cautions us against drawing any firm conclusions from the data about linearity or nonlinearity. A case could be made for either.
If we accept that the OV trajectory is strikingly close to linear, then we are led to ponder why the record life expectancy might have risen in this way. After considerable thought, I find I have little useful to contribute on this important question. I find I am equally unable to explain the relative constancy of age-specific proportional rates of mortality decline, as summarized by the trend in the Lee-Carter (1992) k for the US since 1900, and the G7 countries since 1950 (Tuljapurkar et al, 2000) .
Of the two striking regularities, linear life expectancy trends and constant rate of decline of age-specific mortality, it is the linearity of life expectancy increase which I find most puzzling. In my mind, the risks of death (that is, the force of mortality or death rates, by age) are the fundamental aspect of mortality which we should model and interpret. One view, perhaps an incorrect view, is that period life expectancy is just a very particular and highly nonlinear summary measure, with little or no causal significance. If age-specific death rates (ASDRs) decline at constant exponential rates, then life expectancy will rise at a declining rate, at least for a long time.
This point is worth elaborating because OV, in the Supplementary Materials on the Science Web site, say: "Note that steady rates of change in mortality levels produce steady absolute increases in life expectancy: This relationship may underlie the linear trend of record life expectancy." I agree that ultimately, it is likely that life expectancy would rise linearly, once death rates below the ages which obey Gompertz's Law have fallen to near zero, as Vaupel (1986) has pointed out. If θ is the Gompertz parameter (rate of increase of mortality with age in a period life table or cohort life table) and ρ is the annual rate of decline over time in mortality at all ages above, say, 50, then the rate of increase of e 50 will be ρ/θ years per year (Vaupel, 1986) . However, there is substantial mortality at younger ages before Gompertz's Law applies, particularly in the 19 th century. There we would expect a "steady" rate of decline in death rates to lead to a declining rate of increase in life expectancy.
These points are illustrated in Figure 4 , based on Swedish mortality experience. The average exponential rate of decline is calculated for each age-specific death rate for the period 1861 to 1961. This rate of decline is then applied to the initial age-specific death rates, and used to simulate them forward for 200 years. The resulting life expectancy is plotted in Figure 3 along with the actual life expectancy. It can be seen that the simulated life expectancy trajectory is highly nonlinear, and its pace of improvement decelerates. As time passes, the gains in life expectancy become more nearly linear, and for the last fifty years, are quite close to linear. By construction, the lines cross in 1961. Figure 4 shows that the constant exponential rates of decline in age-specific death rates could not account for the linearity of the increase in record e0 since 1840.
When we look at the trajectories of the logs of the Swedish ASDRs from 1861 to 2000, they appear very far from linear, even if we restrict attention to the last fifty years (see Figure 5 for selected rates). Most rates decline rapidly in some periods, and slowly in others, with patterns varying across the age span. One would not think to characterize these patterns as showing a constant rate of decline at each age. Yet this is a period over
Using These Findings to Improve Mortality Forecasts
The first question is whether or not we should expect record e 0 to continue to increase at this rate in the future, and if so for how long? Since I don't understand why this linearity has occurred in the past, I have no reason to think it should, or should not, continue in the future. The regularity in the past invites the forecaster to assume it will continue in the future, at least for a while. Suppose then that we do assume it will continue. How can we use that assumption to mold our forecasts? This line of thinking leads us unavoidably to consider national mortality change in an international context, to which we now turn.
Considering National Mortality Change in an International Context
Let E(t) be the best-practice life expectancy at time t. It is imperfectly estimated by the OV record series. The White average e 0 measure reflects a different concept. Let e i (t) be actual life expectancy at birth for country i in year t. I will consider a number of possible kinds of models describing the relation between changes in e i (t) and E(t). I will write the equations in continuous time, but they are readily rewritten for discrete annual changes for purposes of estimation. Here, life expectancy tends to increase at some constant rate φ, and in addition it tends to move a proportion α toward the best practice level (record level) E(t) each year. It is also subject to a disturbance ε which could move it toward or away from this trajectory. This specification is consistent with the equation estimated by White. In estimation, I allow the ε i (t) for each country to be autocorrelated ( ( ) ( ) ( )
, with all countries sharing the same autocorrelation coefficient ρ.
I fit this and later models to life expectancy series for 18 countries with relatively low mortality, with data drawn from the Human Mortality Database (HMD) at http://www.mortality.org/. The data series are of varying historical depth, with the shortest covering 29 years and the longest 159 years. Models are fit using an unbalanced design, so that the full range of data could be exploited. However, the estimation range is sometimes restricted to the period since 1900. Table 1a reports estimates of α for females and for males, based on model specifications with and without autocorrelated errors, and using the OV record. In all cases α is highly significantly different than 0, with values lying between .06 and .08, indicating a tendency for the life expectancy of the countries to converge towards the leader country. The half-life of a deviation from the record level is around 10 years (e -10*.07 = .5). Here and throughout, results are very similar if the equation is estimated with no constant, so that the only source of life expectancy increase is catching up with the leader, or if there is no allowance for autocorrelated errors. Note that the R 2 is low at around .04, and that the estimated autocorrelation is negative, which is somewhat surprising. Table 1b is the same, except that it uses the HMD record life expectancy in place of OV. The results are also very similar, but with a slightly slower rate of convergence and lower R 2 .
Rather than taking the actual record e 0 from OV or HMD as an estimate of the target trajectory toward which life expectancy in all countries is tending, we can instead estimate the implicit unobserved target as part of fitting the model, as in the following equation:
Here D t is a period dummy for year t (else 0) and γ t is its coefficient. γ t /α gives the target trajectory, playing a role much like the OV record level. Results are reported in Table 2 (with estimates of γ not shown, to save space). Because the target is chosen to maximize its explanatory power, the R 2 is now much greater, while rates of convergence, α, are somewhat slower. Figure 8 plots the estimated values of γ t /α, corresponding to the implicit target trajectory. For comparison, the record life expectancy for the HMD is also plotted. We see that the target trajectory lies above the maximum about half the time, and also that the target trajectory is highly erratic, possibly with negative autocorrelation.
When life expectancy is generally above trend, as might happen in a year with a mild winter affecting many countries, for example, the regression will try to fit this by estimating a very high target value, and conversely. This will lead to an underestimate of the size of the convergence coefficient, α. To avoid these problems, it is desirable to impose a smoothness constraint of some kind on the target trajectory. Here I will take the simplest route, assuming that the target trajectory is a linear function of time, leading to the following equation:
The results are shown in Table 3 . The estimated rate of convergence, α, is now slightly higher than in the first set of estimates. The rate of increase of the linear target trajectory is found by dividing the coefficient on "year" by the estimate of α, that is the coefficient on -e i,0 , which is also given in the table. The rate of increase in the target calculated in this way is slightly higher than for the record for OV or the HMD. For example, the gain per year in target e 0 estimated here for the whole period is .271 years per year, while in OV it is .243 years per year. Other comparisons are similar.
It is possible that countries that are twice as far from E(t) may not converge twice as quickly. To allow for this, we can add a term that is quadratic in the size of the gap (the quantity in parentheses in equation 0.2). A negative coefficient on the quadratic term would indicate that the pace of increase in e 0 is less than proportionate to the size of the gap, and a positive coefficient that it is more than proportionate.
The results of estimating this specification are given in Table 4 , and are unambiguous: In every case, the coefficient on the quadratic, β, is highly significantly greater than zero, and the coefficient on the linear term is negative. In order to interpret these coefficients, I show in Figure 9 the derivative of the change in e i (t) with respect to the size of the gap, E(t) -e i (t). Under the linear specification used earlier, this plot would be a straight line with height α. Here, however, we see that all the lines slope decisively upward to the right, indicating that the rate of convergence increases more than proportionately with the size of the gap. The initial negative values most likely reflect the limitations of the quadratic specification, rather than a true tendency of the rate of change to decline as the gap increases in this low range. Most of the gaps, 90 to 95% of them, are less than eight years. Only a few fall outside that range, and are subject to the higher sensitivities to the 7 right on the plot. In future work it should be possible to examine the nonlinearity of the response better, drawing on data for Third World countries with higher mortality, but these have not yet been added to the HMD.
Extensions Heterogeneous Targets
If the foregoing models were the whole story, we would expect the life expectancies of countries to be distributed randomly around E(t), since their mortality would have had decades or centuries in which to converge to E(t) under the influences described in the equations. But of course, this is not the case. A more realistic model would take into account the heterogeneity of international experience, by incorporating additional factors that influence the level toward which each country's e 0 converges, which may not be the best practice level. I will call this modified target the idiosyncratic target. We can take it to equal E(t)+ πX(t), where X is a vector of relevant factors and π is a vector of coefficients. X includes relevant variables such as per capita income, educational attainment, nutritional measures, dietary measures, smoking behavior, and geographic/climatic conditions. πX expresses a deviation from the best practice level. Over time, E(t) rises. If X remained constant, the target level would nonetheless increase with E(t). More likely, πX also increases, indicating an additional source of increase in the target level of e 0 . πX could capture influences like those included in Preston's (1980) analysis, in which he fit socioeconomic models to international cross-sections of life expectancy, and then decomposed gains in life expectancy into movements along the πX curve with economic development, and upward shifts in the whole equation, which would here be reflected in the combination of convergence and a common growth rate, φ. The ε shocks could reflect political, military, weather, or epidemiological factors of a transitory nature. This model would be:
Once again, it would be possible to estimate E(t) as part of fitting the model, either unconstrained or constrained to have a linear trajectory. If estimated in this way it will reflect changes in the target net of socioeconomic progress, a concept closer to Preston's residual improvement of life expectancy. Country i will have a target or equilibrium life expectancy in year t of E(t) + πX i,t so heterogeneity in equilibria is now incorporated. Countries that are poor, smoke, eat a high cholesterol diet, have low education, or perhaps have a tropical climate, will tend towards lower levels of life expectancy.
Heterogeneous Rates of Convergence
It is also possible that different countries will have different rates of convergence, α. For isolated countries, or perhaps for very poor ones, or ones with very little transportation or communication infrastructure, α may be smaller. We can take this into account by making α a function of a set of variables Z.
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Forecasting Mortality
Let us assume that the linear trend in record or average life expectancy will continue. Then the next steps are straightforward. We use the linear trend to project the record life expectancy (or the target trend that was estimated as part of the convergence model). We will know the current life expectancy for a particular country of interest. We can use the appropriate or preferred equation for de t /dt to estimate e0 one year later, and then continue recursively. The projected e 0 will gradually approach the projected linear trend.
This procedure could be improved by using a model version which allowed for some heterogeneity, as in equations (.5) and (.6). Not all countries will approach the same trend line, but each should approach a trajectory that is parallel to it. In these specifications, we would also have to consider the advisability of projecting changes in the X and Z variables, and methods for doing so.
The assumption of a pure linear trend could also be questioned, dropping the initial assumption. The central tendency (record, average, or other) could be modeled as a stochastic time series, and forecasted in that way. That could certainly be done for the γ series, for example.
In general, the approach of forecasting mortality for individual countries in reference to the international context is very appealing, and I believe it is the natural way to go in future work. Whether this approach is applied to life expectancy itself, or to a Lee-Carter type k, or in some other way, will have to be settled by further research. In the meantime, these recent papers, and particularly OV, challenge our current perceptions of mortality change and expectations about future trends. Estimates are based on panel corrected standard errors using Prais-Winsten regression (assuming first-order autocorrelation). Standard errors of the coefficients are in brackets. * significant at 5%; ** significant at 1% Estimates are based on panel corrected standard errors using Prais-Winsten regression (assuming first-order autocorrelation). Standard errors of the coefficients are in brackets.* significant at 5%; ** significant at 1% Estimates are based on panel corrected standard errors using Prais-Winsten regression (assuming first-order autocorrelation). Standard errors of the coefficients are in brackets. * significant at 5%; ** significant at 1% Estimates are based on panel corrected standard errors using Prais-Winsten regression (assuming first-order autocorrelation). Standard errors of the coefficients are in brackets. * significant at 5%; ** significant at 1% Estimates are based on panel corrected standard errors using Prais-Winsten regression (assuming first-order autocorrelation). Standard errors of the coefficients are in brackets. * significant at 5%; ** significant at 1% Estimates are based on panel corrected standard errors using Prais-Winsten regression (assuming first-order autocorrelation). Standard errors of the coefficients are in brackets.* significant at 5%; ** significant at 1% Gap (years) Derivative of change with respect to gap Female, 1841 −1999 Female, 1900 −1999 Male, 1841 −1999 Male, 1900 −1999 
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